Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain

Brain Res. 1991 Nov 1;563(1-2):132-6. doi: 10.1016/0006-8993(91)91525-6.

Abstract

The effects of long-term administration of opioid agonists on the regulation of prodynorphin gene expression in rat brain were investigated. Chronic intracerebroventricular treatment with the synthetic opioid agonist acting on the kappa receptor, U-50,488H, and the classic mu agonist morphine markedly decreased prodynorphin mRNA levels in hypothalamus, hippocampus and striatum of tolerant rats. Levels of ir-Dynorphin A remained unchanged except in two cases. Chronic exposure to opiates thus appears to induce modifications of the endogenous opioid system, as regards gene expression regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Analgesics / pharmacology
  • Animals
  • Blotting, Northern
  • Brain Chemistry / drug effects*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • DNA Probes
  • Down-Regulation / drug effects*
  • Enkephalins / biosynthesis*
  • Enkephalins / genetics
  • Gene Expression Regulation / drug effects*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Male
  • Morphine / pharmacology
  • Narcotics / pharmacology*
  • Protein Precursors / biosynthesis*
  • Protein Precursors / genetics
  • Pyrrolidines / pharmacology
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Inbred Strains

Substances

  • Analgesics
  • DNA Probes
  • Enkephalins
  • Narcotics
  • Protein Precursors
  • Pyrrolidines
  • RNA, Messenger
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Morphine
  • preproenkephalin